Acorah Software Products - Accounts Production 16.5.460 false true 31 July 2024 1 August 2023 false 1 August 2024 31 July 2025 31 July 2025 06407717 Ms Adebimpe Joseph iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 06407717 2024-07-31 06407717 2025-07-31 06407717 2024-08-01 2025-07-31 06407717 frs-core:CurrentFinancialInstruments 2025-07-31 06407717 frs-core:PlantMachinery 2025-07-31 06407717 frs-core:PlantMachinery 2024-08-01 2025-07-31 06407717 frs-core:PlantMachinery 2024-07-31 06407717 frs-core:ShareCapital 2025-07-31 06407717 frs-core:RetainedEarningsAccumulatedLosses 2025-07-31 06407717 frs-bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 06407717 frs-bus:FilletedAccounts 2024-08-01 2025-07-31 06407717 frs-bus:SmallEntities 2024-08-01 2025-07-31 06407717 frs-bus:AuditExempt-NoAccountantsReport 2024-08-01 2025-07-31 06407717 frs-bus:SmallCompaniesRegimeForAccounts 2024-08-01 2025-07-31 06407717 frs-bus:Director1 2024-08-01 2025-07-31 06407717 frs-countries:EnglandWales 2024-08-01 2025-07-31 06407717 2023-07-31 06407717 2024-07-31 06407717 2023-08-01 2024-07-31 06407717 frs-core:CurrentFinancialInstruments 2024-07-31 06407717 frs-core:ShareCapital 2024-07-31 06407717 frs-core:RetainedEarningsAccumulatedLosses 2024-07-31
Registered number: 06407717
Amity Pharma Limited
Unaudited Financial Statements
For The Year Ended 31 July 2025
Keystride Consulting
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2—3
Page 1
Balance Sheet
Registered number: 06407717
2025 2024
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 1,315 1,753
1,315 1,753
CURRENT ASSETS
Debtors 5 7,057 -
Cash at bank and in hand 6,277 17,529
13,334 17,529
NET CURRENT ASSETS (LIABILITIES) 13,334 17,529
TOTAL ASSETS LESS CURRENT LIABILITIES 14,649 19,282
NET ASSETS 14,649 19,282
CAPITAL AND RESERVES
Called up share capital 6 100 100
Profit and Loss Account 14,549 19,182
SHAREHOLDERS' FUNDS 14,649 19,282
For the year ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Ms Adebimpe Joseph
Director
06/10/2025
The notes on pages 2 to 3 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
Amity Pharma Limited is a private company, limited by shares, incorporated in England & Wales, registered number 06407717 . The registered office is 10 Dragons Way, Barnet, EN5 2FL.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Equipment 25% on a reducing balance basis
Plant & Machinery 14618
3. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2024: 1)
1 1
4. Tangible Assets
Plant & Machinery
£
Cost
As at 1 August 2024 14,618
As at 31 July 2025 14,618
Depreciation
As at 1 August 2024 12,865
Provided during the period 438
As at 31 July 2025 13,303
Net Book Value
As at 31 July 2025 1,315
As at 1 August 2024 1,753
Page 2
Page 3
5. Debtors
2025 2024
£ £
Due within one year
Other debtors 7,057 -
6. Share Capital
2025 2024
£ £
Allotted, Called up and fully paid 100 100
Page 3